S7 Ep20: Gradishar Stresses the Importance of Accurately Defining Breast Cancer Subtypes

Dr Gradishar emphasizes the importance of defining metastatic breast cancer subtypes, the implications of molecular testing and genetics on treatment decisions, and the need for honest and comprehensive patient-provider communication about therapeutic options and clinical trial opportunities throughout the course of disease.